RemSleep Holdings
699 Walnut Street
Suite 400
DesMoines
Iowa
50266-3962
United States
Tel: 912-590-6048
Website: https://www.remsleeptech.com
About RemSleep Holdings
REMSleep Holdings, Inc. is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions.YEAR FOUNDED:
2007
LEADERSHIP:
Founders: Russell Bird
Founder and CEO: Tom Wood
8 articles about RemSleep Holdings
-
Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)
1/22/2024
RemSleep Holdings Inc., a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea has received a response to the company’s 510 submission K233415.
-
RemSleep Holdings Inc. Issues Letter to Shareholders - Jan 06, 2023
1/6/2023
RemSleep Holdings Inc., a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, provides a corporate update and letter to shareholders from CEO Tom Wood.
-
RemSleep Holdings Provides a Corporate Update on Testing
11/8/2022
RemSleep Holdings Inc., a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the expected last battery of testing will commence this week for final FDA submission of the company’s signature DeltaWave mask.
-
RemSleep Holdings Inc. Commences Trading on OTCQB
7/27/2022
RemSleep Holdings Inc. is pleased to announce that the company’s common shares will begin trading on the OTCQB Market as of the opening of the market on , July 27, 2022.
-
RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company
7/22/2022
RemSleep Holdings Inc. announces the company has formally retained a new Senior Director for Regulatory Compliance and Regulatory submissions to gain FDA clearance to market the company’s medical device respiratory products.
-
RemSleep Holdings Inc. Submits Application For Uplisting to OTCQB
6/10/2022
RemSleep Holdings Inc, a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, announced that the company has officially filed its application for OTCQB® status with otcmarkets.com.
-
RemSleep Holdings Launches New CPAP Mask Designed To Improve Sleep Apnea Patient Comfort And Compliance
8/15/2017
-
RemSleep Holdings ANNOUNCES THE DeltaWave And Its Patent Application -- A New Revolutionary CPAP Nasal Interface Device Designed To Improve Treatment For Sleep Apnea Patients
7/24/2017